EUVIMEDAvasta EUVIMED
BeobachtungsstudieOpen access

Safety and Device Success of Transcatheter Aortic Valve Replacement: A 12‐Year Single‐Center VARC‐3 Report

Juan David Rojas-Perdomo iD, Santiago Uribe-Díaz, Edgar Fernando Hurtado-Ordóñez, Claudia Jaramillo-Villegas, Carlos Alberto Fuentes-Pérez, Michel Perez-Garzon, Henry Robayo-Amortegui iD, Fernan Mendoza-Beltran

Catheterization and Cardiovascular Interventions · 2026-08 · 108 (2) · 602-609

DOI: 10.1002/ccd.70697 ↗

At a glance

Beobachtungsstudie in Catheterization and Cardiovascular Interventions, published online on 2026-06-11. Written by Juan David Rojas-Perdomo and 7 co-authors. Institution: Department of Cardiology. Fundación Clínica Shaio, Bogotá, Colombia. Major MEDLINE topics: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Aortic Valve, Heart Valve Prosthesis. 20 references. The full text is freely available in PubMed Central. Funded by: Fundación Clínica Shaio.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

Transcatheter aortic valve replacement (TAVR) has become an established therapy for severe aortic stenosis (AS) across all surgical risk categories. However, data from Latin America remain scarce, particularly using standardized outcome definitions such as those from the Valve Academic Research Consortium‐3 (VARC‐3).

Aims

To describe baseline characteristics, technical and device success, and early clinical outcomes over a 12‐year period at a single established TAVR program in Colombia.

Methods

We conducted a retrospective observational case series of consecutive patients with severe symptomatic AS who underwent TAVR between January 2012 and December 2023. Data were collected from institutional databases and electronic health records. Outcomes were defined according to VARC‐3 criteria and assessed at 30 days. Procedural success and secondary endpoints were analyzed using the Wilson score method for 95% confidence intervals to account for the sample size. Exploratory temporal trend and multivariable logistic regression analyses were performed.

Results

A total of 134 patients were included (median age 80 years; 52.2% female). Technical success was achieved in 95.5%, and device success at 30 days in 81.3%. Thirty‐day mortality was 7.4%; acute kidney injury (19.4%), permanent pacemaker implantation (18.7%), and vascular complications (12.7%) were the most common adverse events. In an exploratory multivariable model, diabetes mellitus was associated with increased 30‐day mortality (AOR 1.25, 95% CI 1.07–2.41; p = 0.021), although this finding is limited by the low absolute number of events and should be interpreted with caution.

Conclusions

In this 12‐year single‐center experience, TAVR demonstrated high technical and device success with complication rates comparable to international benchmarks. These findings support the feasibility and safety of TAVR in a Latin American setting.

Subjects

MeSH terms (MEDLINE)

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAortic ValveHeart Valve ProsthesisHumansFemaleAged, 80 and overRetrospective StudiesTreatment OutcomeTime FactorsRisk FactorsColombiaMaleRisk AssessmentSeverity of Illness IndexAgedPostoperative ComplicationsProsthesis DesignRecovery of Function

Author keywords

VARC‐3aortic stenosisdeveloping healthcare systemsdevice successlatin americaoutcomesreal‐world datatranscatheter aortic valve replacement

Authors and institutions

  • Department of Cardiology. Fundación Clínica Shaio, Bogotá, Colombia.
  • Department of Hemodynamics and Interventional Cardiology. Fundación Clínica Shaio, Bogotá, Colombia.
  • Department of Critical Care Medicine, Extracorporeal Life Support Unit, Fundación Clínica Shaio, Bogotá, Colombia.
  • School of Medicine, Universidad de La Sabana, Chía, Cundinamarca, Colombia.

ORCID profiles: Juan David Rojas-Perdomo, Henry Robayo-Amortegui

Funding

  • Fundación Clínica Shaio

Cite

APA

Rojas-Perdomo, J. D., Uribe-Díaz, S., Hurtado-Ordóñez, E. F., Jaramillo-Villegas, C., Fuentes-Pérez, C. A., Perez-Garzon, M., Robayo-Amortegui, H., & Mendoza-Beltran, F. (2026). Safety and Device Success of Transcatheter Aortic Valve Replacement: A 12‐Year Single‐Center VARC‐3 Report. Catheterization and Cardiovascular Interventions, 108(2), 602-609. https://doi.org/10.1002/ccd.70697

Vancouver

Rojas-Perdomo JD, Uribe-Díaz S, Hurtado-Ordóñez EF, Jaramillo-Villegas C, Fuentes-Pérez CA, Perez-Garzon M, et al. Safety and Device Success of Transcatheter Aortic Valve Replacement: A 12‐Year Single‐Center VARC‐3 Report. Catheterization and Cardiovascular Interventions. 2026;108(2):602-609. doi:10.1002/ccd.70697

BibTeX
@article{RojasPerdomo2026,
  author = {Rojas-Perdomo, Juan David and Uribe-Díaz, Santiago and Hurtado-Ordóñez, Edgar Fernando and Jaramillo-Villegas, Claudia and Fuentes-Pérez, Carlos Alberto and Perez-Garzon, Michel and Robayo-Amortegui, Henry and Mendoza-Beltran, Fernan},
  title = {Safety and Device Success of Transcatheter Aortic Valve Replacement: A 12‐Year Single‐Center VARC‐3 Report},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {108},
  number = {2},
  pages = {602--609},
  doi = {10.1002/ccd.70697}
}
Start for free →